HIPEC With Interval Cytoreductive Surgery Improves Survival in Ovarian Cancer

In patients with stage III ovarian cancer, the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery significantly improves centrally assessed recurrence-free and overall survival, according to results of a study now published in the International Journal of Gynecological Cancer. By enhancing the penetration of chemotherapy at the peritoneal surface, HIPEC has been found to improve outcomes in patients with advanced ovarian cancer. However, the effi...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.